Table 1 Demographic and clinical characteristics of patients randomized in the ABCSG 28 study, n= 90
Category | In Qol n(%) | no QoLn(%) | P-value | ||
|---|---|---|---|---|---|
Number of patients | |||||
| Â | 79 | 100.0) | 11 | 100.0) | Â |
Menopause Status | |||||
 Perimenopausal | 1 | (1.3) | . | . | 1.0 |
 Postmenopausal | 69 | (87.3) | 9 | (81.8) | |
 Premenopausal | 9 | (11.4) | 2 | (18.2) | |
T-stage | |||||
 cT1 | 15 | (19.0) | 2 | (18.2) | 0.0498 |
 cT2 | 33 | (41.8) | 7 | (63.6) | |
 cT3 | 12 | (15.2) | 1 | (9.1) | |
 cT4 | 16 | (20.3) | . | . | |
 Missing | 3 | (3.8) | 1 | (9.1) | |
N-stage | |||||
 cN0 | 18 | (22.8) | 2 | (18.2) | 0.4261 |
 cN1 | 34 | (43.0) | 7 | (63.6) | |
 cN2 | 9 | (11.4) | . | . | |
 cN3 | 6 | (7.6) | . | . | |
 Missing | 12 | (15.2) | 2 | (18.2) | |
Grading | |||||
 G1 | 5 | (6.3) | 2 | (18.2) | 0.6282 |
 G2 | 44 | (55.7) | 4 | (36.4) | |
 G3 | 24 | (30.4) | 4 | (36.4) | |
 Gx | 3 | (3.8) | 1 | (9.1) | |
 Missing | 3 | (3.8) | . | . | |
HER2 | |||||
 FISH amplif./IHC+++ | 15 | (19.0) | 5 | (45.5) | 0.4475 |
 Negative | 63 | (79.7) | 6 | (54.5) | |
 Missing | 1 | (1.3) | . | . | |
Hormone Status | |||||
 any positive | 65 | (82.3) | 8 | (72.7) | 1.0 |
 Negative | 14 | (17.7) | 3 | (27.3) | |
Tumor Subtype | |||||
 Basal Type | 8 | (10.1) | . | . | 0.8181 |
 HER2 Type | 15 | (19.0) | 5 | (45.5) | |
 Luminal A | 41 | (51.9) | 5 | (45.5) | |
 Luminal B | 11 | (13.9) | 1 | (9.1) | |
 Missing | 4 | (5.1) | . | . | |